BIO-key International Inc. (NASDAQ:BKYI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.72 and traded as low as $0.6738. BIO-key International shares last traded at $0.72, with a volume of 3,958,363 shares.
Analyst Ratings Changes
BKYI has been the subject of a number of recent research reports. Wall Street Zen raised BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, BIO-key International presently has a consensus rating of “Sell”.
View Our Latest Research Report on BIO-key International
BIO-key International Price Performance
Institutional Inflows and Outflows
A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC grew its stake in shares of BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent reporting period. Institutional investors own 26.51% of the company’s stock.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Read More
- Five stocks we like better than BIO-key International
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
